Smart seating company expands team as sales surge and production capacity scales

Kalogon, the market leader in smart seating solutions, today announced it has moved into a dedicated manufacturing facility in Melbourne with production capacity to support up to $50 million in annual business – a major milestone for the company that has built its reputation on U.S.-based innovation and rapid product iteration.

The expansion reflects significant growth, with overall revenue more than doubling and medical revenue nearly tripling year-over-year. After reaching maximum production capacity at Groundswell Startups' campus, Kalogon needed a larger dedicated facility to fulfill accelerating customer demand. Kalogon's vertically integrated approach – designing, prototyping and manufacturing in-house – enables the company to implement improvements based on customer and clinical feedback in days rather than months.

"When your engineering team and production line are under the same roof, speed becomes your competitive advantage," said Tim Balz, CEO and founder of Kalogon. "We hear feedback from a customer in the morning, prototype a solution by afternoon and have it in testing by the end of the week. That cycle would take months with overseas manufacturing. This facility gives us the capacity to scale that speed, introducing new products, expanding customizations and getting innovations to users at a pace that simply isn't possible when you're dependent on external supply chains."

The expansion isn’t just square footage. The company has grown to 35 employees – including recent additions of a specialized industrial sewing technician, multiple engineers and R&D – and is actively hiring across engineering, product and sales to support accelerating demand and innovation.

This agility has proven critical in serving a wide range of use cases, from wheelchair users with diverse needs to passenger comfort on airplanes to high-performance pilots in the U.S. Air Force. Just this year, the company has expanded its medical product line and launched the Bondar back support in multiple sizes, completing a fully Medicare-coded seating solution that combines postural support with Kalogon's proprietary Advanced Pressure Management System (APMS).

"Kalogon represents exactly the kind of sustainable business we want to see thriving in Florida," said Ken Hall, partner at DeepWork Capital, an early investor in Kalogon. “They’ve built a model where rapid iteration and human-centered design create better products faster, and the market is clearly responding. This combination of innovation and commercial traction is exactly what attracts serious investment.”

As urgency for seated health heightens, Kalogon's momentum looks prescient. Kalogon's technology – seating systems that use patented air cell technology, sensors and AI to relieve pressure – addresses growing awareness of seating-related health issues across multiple markets, from wheelchair users managing pressure injury risk to professionals in transportation and aviation seeking enhanced comfort and performance.

The company's smart seating technology has been clinically validated to improve blood flow compared to static cushions and has earned numerous recognitions, including the SXSW Patient Safety Technology Innovation Award and TIME’s Best Inventions. Kalogon serves customers through partnerships with major mobility equipment distributors, including National Seating & Mobility, Numotion and Reliable Medical, as well as direct sales and federal grants.

To learn more about Kalogon, visit https://www.kalogon.com.

About Kalogon

Kalogon is the trusted leader in seated health, delivering inventive seating solutions that eliminate the stresses of sitting. Driven by clinical research, deep customer empathy and rapid product iterations, Kalogon's solutions serve anyone who sits for extended periods, across healthcare, aviation and beyond. Kalogon’s proprietary technology combines real-time sensors, adaptive surfaces and personalized control to restore circulation, protect skin integrity and reduce fatigue. Founded in 2019 and headquartered in Melbourne, Fla., Kalogon manufactures all products in-house and serves customers through clinical partnerships, major DME distributors and direct sales. For more information, visit https://www.kalogon.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251216083329/en/

The expansion reflects significant growth, with overall revenue more than doubling and medical revenue nearly tripling year-over-year.